Nokia (NYSE:NOK) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 6.67 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $7.60 billion which beat the analyst consensus estimate of $7.20 billion by 5.60 percent. This is a 3.64 percent increase over sales of $7.34 billion the same period last year.
Windtree Therapeutics Has Been Granted U.S. Patent Number 11,583,540 Titled “Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure”
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11583540).pn
